These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22870779)

  • 41. Biodegradable thermosensitive polymer gel for sustained BMP-2 delivery.
    Park K
    J Control Release; 2015 Jul; 209():337. PubMed ID: 26048771
    [No Abstract]   [Full Text] [Related]  

  • 42. Randomized controlled trial for efficacy of intra-articular injection for adhesive capsulitis: ultrasonography-guided versus blind technique.
    Lee HJ; Lim KB; Kim DY; Lee KT
    Arch Phys Med Rehabil; 2009 Dec; 90(12):1997-2002. PubMed ID: 19969160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlling drug nanoparticle formation by rapid precipitation.
    D'Addio SM; Prud'homme RK
    Adv Drug Deliv Rev; 2011 May; 63(6):417-26. PubMed ID: 21565233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosin nanoparticles as a drug delivery carrier for the controlled release of hydrocortisone.
    Lee CM; Lim S; Kim GY; Kim DW; Rhee JH; Lee KY
    Biotechnol Lett; 2005 Oct; 27(19):1487-90. PubMed ID: 16231221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical experience and scientific evidence].
    Sharma S
    Tidsskr Nor Laegeforen; 2004 May; 124(10):1423; author reply 1423-4. PubMed ID: 15195191
    [No Abstract]   [Full Text] [Related]  

  • 46. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs.
    Serpe L; Canaparo R; Foglietta F; Zara GP
    Curr Pharm Des; 2013; 19(41):7219-36. PubMed ID: 23489201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liposomal nanostructures for photosensitizer delivery.
    Jin CS; Zheng G
    Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term effects of intra-articular sodium hyaluronate, glucocorticoid, and saline injections on rheumatoid arthritis of the temporomandibular joint.
    Kopp S; Akerman S; Nilner M
    J Craniomandib Disord; 1991; 5(4):231-8. PubMed ID: 1814964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy of intra-articular hyaluronan injection after the microfracture technique for the treatment of articular cartilage lesions.
    Strauss E; Schachter A; Frenkel S; Rosen J
    Am J Sports Med; 2009 Apr; 37(4):720-6. PubMed ID: 19204370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Joint aspiration and injection.
    Courtney P; Doherty M
    Best Pract Res Clin Rheumatol; 2005 Jun; 19(3):345-69. PubMed ID: 15939363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization and optimization of GMO-based gels with long term release for intraarticular administration.
    Réeff J; Gaignaux A; Goole J; Siepmann J; Siepmann F; Jerome C; Thomassin JM; De Vriese C; Amighi K
    Int J Pharm; 2013 Jul; 451(1-2):95-103. PubMed ID: 23651644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overcoming barriers by local drug delivery with liposomes.
    Antimisiaris SG; Marazioti A; Kannavou M; Natsaridis E; Gkartziou F; Kogkos G; Mourtas S
    Adv Drug Deliv Rev; 2021 Jul; 174():53-86. PubMed ID: 33539852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New aspects in sustained drug release formulations.
    Bikiaris D; Koutris E; Karavas E
    Recent Pat Drug Deliv Formul; 2007; 1(3):201-13. PubMed ID: 19075887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liposomal drug formulations. Rationale for development and what we can expect for the future.
    Allen TM
    Drugs; 1998 Nov; 56(5):747-56. PubMed ID: 9829150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-Bearing Supramolecular Filament Hydrogels as Anti-Inflammatory Agents.
    Chen Z; Xing L; Fan Q; Cheetham AG; Lin R; Holt B; Chen L; Xiao Y; Cui H
    Theranostics; 2017; 7(7):2003-2014. PubMed ID: 28656057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heart targeted nanoliposomal/nanoparticles drug delivery: An updated review.
    Cheraghi M; Negahdari B; Daraee H; Eatemadi A
    Biomed Pharmacother; 2017 Feb; 86():316-323. PubMed ID: 28011379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of hyaluronic acid as carriers in drug delivery.
    Huang G; Huang H
    Drug Deliv; 2018 Nov; 25(1):766-772. PubMed ID: 29536778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.